|
Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas BollykyThe Atlantic Apr. 14, 2013 |
Popular 
IDF Soldier Takes Sledgehammer to Jesus Statue During Operations in Lebanon
Mark Levin and Jonathan Pollard Push for Nuking Iran
Reuters: Trump Approved Iran Strikes After Speaking With Netanyahu
Trump Expected to Pick Kevin Warsh, Son-in-Law of Zionist Billionaire Ron Lauder, as Fed Chair
Trump Says U.S. Sent 'A Lot of Guns' to Iranian 'Protesters'
 Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India? It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India. Read More 
|
